Since the outset of the COVID-19 pandemic, 10 to 30% of the general population has experienced some form of virus-induced cognitive impairment, including trouble concentrating, brain fog or memory loss. This led a team of ...
Jun 27, 2024
0
48
Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer's disease, ...
Aug 16, 2023
0
63
Moderna has developed a new and improved version of its COVID-19 vaccine. The unique formulation (mRNA-1283) reduces the vaccine's content from the full-length SARS-CoV-2 spike protein to a narrowly focused encoding of just ...
As the HIV virus glides up outside a human cell to dock and possibly inject its deadly cargo of genetic code, there's a spectacularly brief moment in which a tiny piece of its surface snaps open to begin the process of infection.
Feb 2, 2024
0
111
After having successfully tested a mucosal vaccine against coronavirus in animals just months ago, Berlin scientists have now further developed their live SARS-CoV-2 vaccine. Researchers at Freie Universität Berlin have ...
Jun 13, 2023
0
100
New research from scientists at La Jolla Institute for Immunology (LJI) suggests people who received COVID-19 vaccines and then experienced "breakthrough" infections are especially well armed against future SARS-CoV-2 infections.
May 24, 2024
0
122
In the first 10 months of availability, COVID-19 vaccines prevented around 235,000 deaths and 1.6 million hospitalizations in the U.S. However, by April 2023, 19% of Americans still hadn't received their first vaccine dose ...
Jun 27, 2024
0
23
Research by the Norwegian Institute of Public Health, Norway, suggests that COVID-19 vaccines or the body's response to them can lead to unexpected vaginal bleeding in women. This phenomenon was observed in women across different ...
According to an accepted manuscript published in ARRS' American Journal of Roentgenology (AJR), axillary lymphadenopathy after a COVID-19 vaccine booster dose has a mean time to resolution of 102 days, shorter than the time ...
Mar 9, 2023
0
35
In the 35 years before the COVID-19 pandemic, the U.S. government invested at least $337 million into critical research that led to the mRNA COVID-19 vaccines, according to a study published by The BMJ today.
Mar 1, 2023
0
88
